1. Cingulate dynamics track depression recovery with deep brain stimulation.
- Author
-
Alagapan S, Choi KS, Heisig S, Riva-Posse P, Crowell A, Tiruvadi V, Obatusin M, Veerakumar A, Waters AC, Gross RE, Quinn S, Denison L, O'Shaughnessy M, Connor M, Canal G, Cha J, Hershenberg R, Nauvel T, Isbaine F, Afzal MF, Figee M, Kopell BH, Butera R, Mayberg HS, and Rozell CJ
- Subjects
- Humans, Artificial Intelligence, Biomarkers, Electrophysiology, Treatment Outcome, Local Field Potential Measurement, White Matter, Limbic Lobe physiology, Limbic Lobe physiopathology, Facial Expression, Deep Brain Stimulation methods, Depression physiopathology, Depression therapy, Depressive Disorder, Major physiopathology, Depressive Disorder, Major therapy
- Abstract
Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) can provide long-term symptom relief for treatment-resistant depression (TRD)
1 . However, achieving stable recovery is unpredictable2 , typically requiring trial-and-error stimulation adjustments due to individual recovery trajectories and subjective symptom reporting3 . We currently lack objective brain-based biomarkers to guide clinical decisions by distinguishing natural transient mood fluctuations from situations requiring intervention. To address this gap, we used a new device enabling electrophysiology recording to deliver SCC DBS to ten TRD participants (ClinicalTrials.gov identifier NCT01984710). At the study endpoint of 24 weeks, 90% of participants demonstrated robust clinical response, and 70% achieved remission. Using SCC local field potentials available from six participants, we deployed an explainable artificial intelligence approach to identify SCC local field potential changes indicating the patient's current clinical state. This biomarker is distinct from transient stimulation effects, sensitive to therapeutic adjustments and accurate at capturing individual recovery states. Variable recovery trajectories are predicted by the degree of preoperative damage to the structural integrity and functional connectivity within the targeted white matter treatment network, and are matched by objective facial expression changes detected using data-driven video analysis. Our results demonstrate the utility of objective biomarkers in the management of personalized SCC DBS and provide new insight into the relationship between multifaceted (functional, anatomical and behavioural) features of TRD pathology, motivating further research into causes of variability in depression treatment., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF